Literature DB >> 21632729

Potential disparities in the management of schizophrenia in the United States.

Kathryn Rost1, Yi-Ping Hsieh, Stanley Xu, Nir Menachemi, Alexander S Young.   

Abstract

OBJECTIVE: This study investigated whether outpatient visits to psychiatrists and primary care physicians (family physicians, general internists, or general practitioners) by individuals with schizophrenia differed in antipsychotic medication management and subsequent hospitalization by age, gender, race-ethnicity, insurance, rurality, and region.
METHODS: Data for the study were from office visit forms completed between 1999 and 2007 by physicians in the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. A total of 3,359 outpatient visits by individuals with a diagnosis of schizophrenia were identified. The research team used four logistic regression models to test the relationship of sociodemographic variables to antipsychotic medication management during the visit and to hospitalization after the visit. The four models controlled for available clinical covariates with or without physician specialty in the entire cohort and in the cohort of visits in which patients had no active psychotic symptoms.
RESULTS: In at least three of the four models, the research team observed that visits by non-Hispanic black patients had significantly (p<.05) greater odds of involving antipsychotic medication management than visits by non-Hispanic whites (range of odds ratios [ORs] 1.66 to 1.88) and of resulting in hospitalization (range of ORs, 3.52 to 6.95). In all four models, visits by patients who lacked insurance were significantly less likely to result in hospitalization than visits by patients who had private insurance (OR=<.001 in all models).
CONCLUSIONS: These findings provide the first national evidence of potential treatment disparities for schizophrenia. Further research is needed to definitively identify disparities and to understand their causes and consequences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632729     DOI: 10.1176/ps.62.6.pss6206_0613

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  5 in total

Review 1.  Mental Health Disparities, Treatment Engagement, and Attrition Among Racial/Ethnic Minorities with Severe Mental Illness: A Review.

Authors:  Jessica Maura; Amy Weisman de Mamani
Journal:  J Clin Psychol Med Settings       Date:  2017-12

2.  Interviewer-perceived honesty as a mediator of racial disparities in the diagnosis of schizophrenia.

Authors:  Shaun M Eack; Amber L Bahorik; Christina E Newhill; Harold W Neighbors; Larry E Davis
Journal:  Psychiatr Serv       Date:  2012-09-01       Impact factor: 3.084

Review 3.  Improving Behavioral Health Services in the Time of COVID-19 and Racial Inequities.

Authors:  Ruth S Shim; Matthew Tierney; Martin H Rosenzweig; Howard H Goldman
Journal:  NAM Perspect       Date:  2021-11-01

Review 4.  A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States.

Authors:  Wenjie Zhang; Tony B Amos; Stephen W Gutkin; Nicole Lodowski; Emma Giegerich; Kruti Joshi
Journal:  Clinicoecon Outcomes Res       Date:  2018-06-08

5.  Implicit bias of encoded variables: frameworks for addressing structured bias in EHR-GWAS data.

Authors:  Hillary R Dueñas; Carina Seah; Jessica S Johnson; Laura M Huckins
Journal:  Hum Mol Genet       Date:  2020-09-30       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.